DEXCOM, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
DEXCOM, INC. (DXCM) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$200.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-25.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2015-02-25
- DEXCOM, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2014-12-31 was $500.00K, a 0.00% change year-over-year.
- DEXCOM, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2014-09-30 was -$900.00K, a 190.00% decline year-over-year.
- DEXCOM, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2014-06-30 was -$1.00M, a 242.86% decline year-over-year.
- DEXCOM, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2014-03-31 was $1.20M, a 300.00% increase year-over-year.
- DEXCOM, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2014 was -$200.00K, a 108.00% decline from fiscal 2013.
- DEXCOM, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2013 was $2.50M, a 316.67% increase from fiscal 2012.
- DEXCOM, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2012 was $600.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|---|---|---|
| 2014-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | -$400.00K derived: sum of 2 quarters · filed 2015-02-25 | -$1.40M derived: sum of 3 quarters · filed 2015-02-25 | -$200.00K 10-K · filed 2015-02-25 | |||
| 2014-09-30 | -$900.00K 10-Q · filed 2014-11-06 | -$1.90M derived: sum of 2 quarters · filed 2014-11-06 | -$700.00K 10-Q · filed 2014-11-06 | -$200.00K derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2014-06-30 | -$1.00M 10-Q · filed 2014-08-06 | $200.00K 10-Q · filed 2014-08-06 | $700.00K derived: sum of 3 quarters · filed 2015-02-25 | $1.70M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2014-03-31 | $1.20M 10-Q · filed 2014-05-01 | $1.70M derived: sum of 2 quarters · filed 2015-02-25 | $2.70M derived: sum of 3 quarters · filed 2015-02-25 | $3.40M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $1.50M derived: sum of 2 quarters · filed 2015-02-25 | $2.20M derived: sum of 3 quarters · filed 2015-02-25 | $2.50M 10-K · filed 2015-02-25 | |||
| 2013-09-30 | $1.00M 10-Q · filed 2014-11-06 | $1.70M derived: sum of 2 quarters · filed 2014-11-06 | $2.00M 10-Q · filed 2014-11-06 | $1.70M derived: sum of 4 quarters · filed 2014-11-06 | |||
| 2013-06-30 | $700.00K 10-Q · filed 2014-08-06 | $1.00M 10-Q · filed 2014-08-06 | $700.00K derived: sum of 3 quarters · filed 2014-08-06 | $1.00M derived: sum of 4 quarters · filed 2014-08-06 | |||
| 2013-03-31 | $300.00K 10-Q · filed 2014-05-01 | $0.00 derived: sum of 2 quarters · filed 2014-05-01 | $300.00K derived: sum of 3 quarters · filed 2014-05-01 | $1.00M derived: sum of 4 quarters · filed 2014-05-01 | |||
| 2012-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $0.00 derived: sum of 2 quarters · filed 2014-02-20 | $700.00K derived: sum of 3 quarters · filed 2014-02-20 | $600.00K 10-K · filed 2014-02-20 | |||
| 2012-09-30 | $300.00K 10-Q · filed 2013-11-06 | $278.00K 10-Q · filed 2012-11-01 | $1.00M derived: sum of 2 quarters · filed 2013-11-06 | $900.00K 10-Q · filed 2013-11-06 | $940.00K 10-Q · filed 2012-11-01 | ||
| 2012-06-30 | $700.00K 10-Q · filed 2013-08-07 | $608.00K 10-Q · filed 2012-08-06 | $700.00K 10-Q · filed 2013-08-07 | $662.00K 10-Q · filed 2012-08-06 | |||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-01 | ||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-01 | $0.00 derived: sum of 2 quarters · filed 2012-11-01 | $0.00 10-Q · filed 2012-11-01 | ||||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-06 | $0.00 10-Q · filed 2012-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |